R. Jones

R. Jones, T. Fritsche, H. Sader, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary (2010) European Pathogens Isolated from Patients with Acute Bacterial Skin and Skin-Structure Infections

P. Rhomberg, D. Farrell, R. Jones, 2011 .

Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

M. Pfaller, D. Diekema, R. Jones, 2003, Journal of Clinical Microbiology.

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.

M. Pfaller, G. Doern, D. Diekema, 2000, International journal of antimicrobial agents.

M. Pfaller, D. Diekema, R. Jones, 2002, International journal of antimicrobial agents.

In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates

M. Pfaller, D. Diekema, R. Jones, 2003, Antimicrobial Agents and Chemotherapy.

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

R. Jones, A. Gales, H. Sader, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Re-evaluation of the Role of Broad-Spectrum Cephalosporins Against Staphylococci by Applying Contemporary In-Vitro Results and Pharmacokinetic- Pharmacodynamic Principles

M. Pfaller, R. Jones, S. Bhavnani, 2007, Journal of chemotherapy.

Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.

R. Jones, A. Gales, H. Sader, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.

M. Pfaller, G. Doern, R. Jones, 1999, Diagnostic microbiology and infectious disease.

Daptomycin Activity and Spectrum when Tested against Contemporary (2009) Gram-positive Strains Collected in European Medical Centers

S. Putnam, H. Sader, R. Jones, 2010 .

Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.

M. Pfaller, R. Jones, S. Messer, 1998, Diagnostic microbiology and infectious disease.

In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from Blood

M. Pfaller, D. Diekema, R. Jones, 2003, Journal of Clinical Microbiology.

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

R. Jones, T. Fritsche, R. Jones, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Plate for Antifungal Susceptibility Testing of the New Triazoles Voriconazole, Posaconazole, and Ravuconazole

M. Pfaller, R. Jones, A. Espinel-Ingroff, 2004, Journal of Clinical Microbiology.

Solithromycin MIC and Disk Diffusion Quality Control Ranges, a CLSI Multi-Laboratory M23-A3 Study Design

D. Farrell, R. Flamm, J. Ross, 2015 .

Antimicrobial Activity of Solithromycin (CEM-101), a Novel Fluoroketolide, Tested Against Isolates Collected in Europe during 2010 Surveillance

H. Sader, D. Farrell, R. Jones, 2011 .

Antimicrobial Activity of a New Fluoroketolide Solithromycin (CEM-101) Tested Against Fastidious Gram-negative Community-Acquired Bacterial Pneumonia Pathogens

H. Sader, D. Farrell, R. Jones, 2010 .